Trial Profile
Clinical Trial to Compare Topical Interferon Alfa 2b And Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary) ; Mitomycin
- Indications Conjunctival disorders; Corneal disorders; Glandular and epithelial neoplasms
- Focus Therapeutic Use
- 07 Aug 2017 Status changed from active, no longer recruiting to completed.
- 07 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Mar 2017.
- 05 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.